Goodwin has advised Gilde Healthcare’s Surgical Instrument Contract Manufacturing Group (“Gilde Healthcare”) on the financing of the acquisition of Rudischhauser Surgical Instruments Manufacturing GmbH (“Rudischhauser”), marking a significant milestone in the creation of a leading contract manufacturing group for precision surgical instruments.
Rudischhauser is specialized in the manufacturing of complex surgical instruments and implants. They serve leading international MedTech companies especially in the spine, orthopedics, and traumatology space. Founded in 1954, the company provides advanced manufacturing processes and state-of-the-art quality certifications including FDA compliance.
Gilde Healthcare is a thematic investor managing over €2.6 billion across two healthcare-focused fund strategies: Private Equity and Venture & Growth. Gilde Healthcare’s private equity fund invests in profitable lower mid-market healthcare companies based in Northwest Europe. Gilde Healthcare’s Venture & Growth fund invests in digital healthcare solutions, medical technology, and therapeutics based in Europe and North America.
The team was led by Winfried M. Carli and Daniel Wagner and included Rina Omura (all Private Equity/Debt Finance, Munich).